Corporate Finance : Fundamentals of Capital Budgeting
As a new member of the capital budgeting
division of Novo Nordisk A/S, you have been asked to determine the net cash flows and the NPV of a proposed new diabetes drug. The drug is expected to be on the market for three years only, because Novo expects to launch a new and better version of the drug in the near future. If the project is initiated, it will require an upfront (that is, year zero) expenditure on the R&D of 4% of the total amount that Novo spent on the R&D in the last financial year. Also an investment in a new production facility, which is estimated to cost $141.35 million, will be necessary.
The product revenues for years 1, 2, and 3 are expected to be 0.8%, 0.6%, and 0.4%, respectively, of the total revenue of Novo for the last financial year. The cost of goods sold (COGS) is projected to be the same percentage of the sales as in the last financial year. The overheads (sales, general, and administrative costs) are assumed to be 179.78 million EUR in the first two years and 152.54 million EUR in the last one.
Recently Asked Questions
- You feel very strongly that the stock in McDonald's Corporation is about to fall from its present level of $85 per share. You call your broker and have him
- Suppose you borrow 25000 $ and rate 9.5% and must repay in equal 4 instulmant at the end of the next 4 years , how much would you still owe at the end of the
- Aaron's chairs is in the process of preparing a production cost budget for August. Actual costs in July for 120 chairs were: Material cost: $4,900 Labor cost: